63 related articles for article (PubMed ID: 18537814)
1. The determinants of traditional Chinese medicine and acupuncture utilization for cancer patients with simultaneous conventional treatment.
Pu CY; Lan VM; Lan CF; Lang HC
Eur J Cancer Care (Engl); 2008 Jul; 17(4):340-9. PubMed ID: 18537814
[TBL] [Abstract][Full Text] [Related]
2. Scientific evidence on the supportive cancer care with Chinese medicine.
Cho WC
Zhongguo Fei Ai Za Zhi; 2010 Mar; 13(3):190-4. PubMed ID: 20673514
[TBL] [Abstract][Full Text] [Related]
3. Traditional Chinese Medicine for Breast Cancer: A Review.
Feng RQ; Li DH; Liu XK; Zhao XH; Wen QE; Yang Y
Breast Cancer (Dove Med Press); 2023; 15():747-759. PubMed ID: 37915543
[TBL] [Abstract][Full Text] [Related]
4. Acupuncture in cancer care: a narrative review.
Tsai AWW; D'Alessandro E; Brandão S; Guerreiro JB; Bassetto RM; Bandeira JS; Pai MYB; Höhl A; Silva AVD; Sant'Anna FM
Rev Assoc Med Bras (1992); 2024; 70(suppl 1):e2024S101. PubMed ID: 38865521
[No Abstract] [Full Text] [Related]
5. Quantitative analysis and visualization of literature on acupuncture and related TCM therapies for the treatment of colorectal cancer based on CiteSpace.
Li Z; Xiong Q; Li S; Chen W; Xu N; Qiu F
Front Oncol; 2023; 13():1290588. PubMed ID: 38250554
[TBL] [Abstract][Full Text] [Related]
6. The intention of utilization and experience toward traditional Chinese medicine among breast cancer patients in the early and late stages: a qualitative study.
Chen KW; Chung KP; Hsu CH
BMC Complement Med Ther; 2023 Jul; 23(1):226. PubMed ID: 37420247
[TBL] [Abstract][Full Text] [Related]
7. The Use of San-Huang-Xie-Xin-Tang Reduces the Mortality Rate among Breast Cancer Patients.
Winardi D; Wu CH; Chiang JH; Chen YH; Hsieh CL; Yang JC; Wu YC
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831555
[TBL] [Abstract][Full Text] [Related]
8. Improved Aitongxiao prescription (I-ATXP) induces apoptosis, cell cycle arrest and blocks exosomes release in hepatocellular carcinoma (HCC) cells.
Huang MB; Gao Z; Xia M; Zhao X; Fan X; Lin S; Zhang L; Huang L; Wei A; Zhou H; Wu JY; Roth WW; Bond VC; Leng J
Int J Physiol Pathophysiol Pharmacol; 2022; 14(2):90-113. PubMed ID: 35619665
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of acupuncture and moxibustion combined with the external application of traditional Chinese medicine in the treatment of primary liver cancer: A protocol for systematic review and meta-analysis.
Wang S; Xiong Z; Liu Y; Leng Y; Deng H; Shen D; Meng X; Liu T
Medicine (Baltimore); 2021 Oct; 100(43):e27659. PubMed ID: 34713860
[TBL] [Abstract][Full Text] [Related]
10. Oridonin inhibits metastasis of human ovarian cancer cells by suppressing the mTOR pathway.
Wang Y; Zhu Z
Arch Med Sci; 2019 Jul; 15(4):1017-1027. PubMed ID: 31360196
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Different Patterns of Traditional Chinese Medicine Treatment and All-Cause Mortality Among Cancer Patients.
Lu SY; Chen JJ; Pan JI; Fu ZX; Wu JL; Hsieh TC
Integr Cancer Ther; 2019; 18():1534735418823273. PubMed ID: 30791738
[TBL] [Abstract][Full Text] [Related]
12. β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial-Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling.
Cao ZQ; Wang XX; Lu L; Xu JW; Li XB; Zhang GR; Ma ZJ; Shi AC; Wang Y; Song YJ
Front Pharmacol; 2018; 9():1525. PubMed ID: 30670971
[TBL] [Abstract][Full Text] [Related]
13. Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study.
Kuo YT; Chang TT; Muo CH; Wu MY; Sun MF; Yeh CC; Yen HR
Integr Cancer Ther; 2018 Jun; 17(2):531-541. PubMed ID: 28665160
[TBL] [Abstract][Full Text] [Related]
14. Utilization and prescription patterns of traditional Chinese medicine for patients with hepatitis C in Taiwan: a population-based study.
Liu CY; Chu JY; Chiang JH; Yen HR; Hsu CH
BMC Complement Altern Med; 2016 Oct; 16(1):397. PubMed ID: 27769222
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro.
Ayeka PA; Bian Y; Mwitari PG; Chu X; Zhang Y; Uzayisenga R; Otachi EO
BMC Complement Altern Med; 2016 Jul; 16():206. PubMed ID: 27401917
[TBL] [Abstract][Full Text] [Related]
16. Complementary and Integrative Health Practices Among Hispanics Diagnosed with Colorectal Cancer: Utilization and Communication with Physicians.
Black DS; Lam CN; Nguyen NT; Ihenacho U; Figueiredo JC
J Altern Complement Med; 2016 Jun; 22(6):473-9. PubMed ID: 27163178
[TBL] [Abstract][Full Text] [Related]
17. Use of Chinese herbal medicine therapies in comprehensive hospitals in central China: A parallel survey in cancer patients and clinicians.
Chen G; Qiao TT; Ding H; Li CX; Zheng HL; Chen XL; Hu SM; Yu SY
J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):808-814. PubMed ID: 26670429
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria.
Wang Y; Yu RY; He QY
Evid Based Complement Alternat Med; 2015; 2015():539260. PubMed ID: 26568766
[TBL] [Abstract][Full Text] [Related]
19. Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells.
Kuo CC; Chen JJ; Tsai JY; Hsueh CT
Biomark Res; 2014; 2(1):26. PubMed ID: 25553241
[TBL] [Abstract][Full Text] [Related]
20. Use of Chinese medicine among colorectal cancer patients: a nationwide population-based study.
Tsai SJ; Ruan YX; Lee CC; Lee MS; Chiou WY; Lin HY; Hsu FC; Su YC; Hsu TW; Hung SK
Afr J Tradit Complement Altern Med; 2014; 11(2):343-349. PubMed ID: 25435620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
